Bernhard Ehmer joins board of Achilles

Friday 13 May 2022
Achilles Therapeutics Plc
Appointee name
Bernhard Ehmer

United Kingdom

Achilles Therapeutics Plc has appointed the biopharmaceutical veteran Bernhard Ehmer to its board of directors as it advances its T cell therapies for cancer in the clinic. Dr Ehmer most recently served as chief executive of Biotest AG, a specialist supplier of plasma proteins and biotherapeutic drugs. He has also served as chairman of the board of directors of Symphogen A/S of Denmark until its acquisition by Servier SA in 2020.

Achilles announced the appointment on 4 May 2022.

Copyright 2022 Evernow Publishing Ltd